Key Findings

The study identifies 4′,5′-O-dicaffeoylquinic acid (4′,5′-O DCQA) as an effective efflux pump inhibitor targeting the NorA efflux system in Gram-positive bacteria, enhancing the efficacy of antimicrobials like berberine, ethidium bromide, and fluoroquinolones.